常廣 Stock: price and insider trades · Taiwan

Every trade that managers of 常廣 disclose to TWSE / TPEx (MOPS) is tracked on this page. The company sits in the Health Care sector. In the past year (28 October 2025 to 28 October 2026), 4 filings came from 4 insiders.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

For context, the typical company on the same exchange (median of 619 companies) published 2 filings over the same period, against 4 filings here.

There has been no open-market purchase by an insider of 常廣 for at least a year. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.